Us Stem Cell Stock Return On Equity
| USRMDelisted Stock | USD 0.0002 0.00 0.00% |
US Stem Cell fundamentals help investors to digest information that contributes to US Stem's financial success or failures. It also enables traders to predict the movement of USRM Pink Sheet. The fundamental analysis module provides a way to measure US Stem's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to US Stem pink sheet.
USRM |
US Stem Cell Company Return On Equity Analysis
US Stem's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, US Stem Cell has a Return On Equity of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The return on equity for all United States stocks is 100.0% lower than that of the firm.
USRM Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses US Stem's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of US Stem could also be used in its relative valuation, which is a method of valuing US Stem by comparing valuation metrics of similar companies.US Stem is currently under evaluation in return on equity category among its peers.
USRM Fundamentals
| Return On Asset | -8.45 | ||||
| Operating Margin | (19.95) % | ||||
| Current Valuation | 12.15 M | ||||
| Shares Outstanding | 634.4 M | ||||
| Shares Owned By Insiders | 10.68 % | ||||
| Price To Earning | (1.12) X | ||||
| Price To Sales | 30.36 X | ||||
| Revenue | 3.07 M | ||||
| Gross Profit | 148.72 K | ||||
| EBITDA | (2.61 M) | ||||
| Net Income | (3.84 M) | ||||
| Cash And Equivalents | 10.33 K | ||||
| Total Debt | 722.06 K | ||||
| Debt To Equity | (1.03) % | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (1.21 M) | ||||
| Earnings Per Share | (0.01) X | ||||
| Target Price | 0.4 | ||||
| Number Of Employees | 15 | ||||
| Beta | -0.69 | ||||
| Market Capitalization | 3.05 M | ||||
| Total Asset | 89.84 K | ||||
| Retained Earnings | (122.08 M) | ||||
| Working Capital | (6.64 M) | ||||
| Current Asset | 320 K | ||||
| Current Liabilities | 6.96 M | ||||
| Net Asset | 89.84 K |
About US Stem Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze US Stem Cell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of US Stem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of US Stem Cell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in USRM Pink Sheet
If you are still planning to invest in US Stem Cell check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the US Stem's history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |